BioCryst Pharmaceuticals Inc (BCRX)
6.66
+0.24
(+3.74%)
USD |
NASDAQ |
May 22, 16:00
6.56
-0.10
(-1.50%)
After-Hours: 20:00
BioCryst Pharmaceuticals Free Cash Flow: -103.56M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -103.56M |
| December 31, 2023 | -97.31M |
| September 30, 2023 | -112.21M |
| June 30, 2023 | -123.95M |
| March 31, 2023 | -132.67M |
| December 31, 2022 | -163.20M |
| September 30, 2022 | -172.39M |
| June 30, 2022 | -163.42M |
| March 31, 2022 | -161.64M |
| December 31, 2021 | -144.54M |
| September 30, 2021 | -153.66M |
| June 30, 2021 | -168.45M |
| March 31, 2021 | -173.34M |
| December 31, 2020 | -135.62M |
| September 30, 2020 | -103.46M |
| June 30, 2020 | -92.76M |
| March 31, 2020 | -86.23M |
| December 31, 2019 | -89.93M |
| September 30, 2019 | -103.49M |
| June 30, 2019 | -110.84M |
| March 31, 2019 | -100.33M |
| December 31, 2018 | -92.93M |
| September 30, 2018 | -79.48M |
| June 30, 2018 | -57.02M |
| March 31, 2018 | -52.63M |
| Date | Value |
|---|---|
| December 31, 2017 | -41.47M |
| September 30, 2017 | -36.69M |
| June 30, 2017 | -41.81M |
| March 31, 2017 | -45.14M |
| December 31, 2016 | -58.72M |
| September 30, 2016 | -71.74M |
| June 30, 2016 | -66.80M |
| March 31, 2016 | -36.05M |
| December 31, 2015 | -18.24M |
| September 30, 2015 | -13.32M |
| June 30, 2015 | -9.151M |
| March 31, 2015 | -33.98M |
| December 31, 2014 | -38.66M |
| September 30, 2014 | -29.22M |
| June 30, 2014 | -28.51M |
| March 31, 2014 | -24.33M |
| December 31, 2013 | -26.56M |
| September 30, 2013 | -29.07M |
| June 30, 2013 | -32.93M |
| March 31, 2013 | -36.39M |
| December 31, 2012 | -37.51M |
| September 30, 2012 | -34.47M |
| June 30, 2012 | -33.15M |
| March 31, 2012 | -30.27M |
| December 31, 2011 | -32.31M |
Free Cash Flow Range, Past 5 Years
-173.34M
Minimum
Mar 2021
-86.23M
Maximum
Mar 2020
-129.63M
Average
-128.31M
Median
Free Cash Flow Benchmarks
| Integra Lifesciences Holdings Corp | 60.93M |
| Nortech Systems Inc | 1.347M |
| Novavax Inc | -514.43M |
| SINTX Technologies Inc | -12.44M |
| Allogene Therapeutics Inc | -227.48M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -53.68M |
| Cash from Investing (Quarterly) | 28.76M |
| Cash from Financing (Quarterly) | -1.048M |
| Free Cash Flow Per Share (Quarterly) | -0.2617 |
| Free Cash Flow to Equity (Quarterly) | -55.69M |
| Free Cash Flow to Firm (Quarterly) | -33.23M |
| Free Cash Flow Yield | -7.91% |